What it is
KLOW is the shorthand the peptide-education community uses for a combination formulation typically described as GHK-Cu + KPV + BPC-157 + TB-500.
How it's described to work
The rationale discussed in literature is complementary signaling: repair-oriented peptides paired with anti-inflammatory and skin/tissue-oriented peptides.
What research discusses it for
Recovery researchSkin and tissue researchCombination protocol discussion
Important context
Blends compound the unknowns of each component. Nothing on this page is a recommendation or an offer to sell.